Presentations Medicenna Therapeutics Corp. - Corporate Presentation Q4 2022 Past Events November 19 - November 21, 2020 2020 Society for Neuro-Oncology (SNO) Annual Meeting Go to November 16, 2020 at 4:40 PM EST Stifel 2020 Virtual Healthcare Conference Go to November 3, 2020 at 9:50 AM EST Next-Gen Cytokine Therapeutics Summit Go to October 29, 2020 from 11:00 AM to 12:30 PM EDT Virtual TSX Life Sciences Investor Day Go to October 24 - October 25, 2020 MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit Go to October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to Pagination First page « first Previous page ‹ previous … Page 3 Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Next page next › Last page last »
October 24 - October 25, 2020 MDNA55, a Locally Administered IL4 Guided Toxin for Targeted Treatment of Recurrent Glioblastoma Shows Long Term Survival Benefit Go to
October 24 - October 25, 2020 Emergence of Novel Long-acting Mono- and Bi-specific IL-2/IL-13 Superkines as Potent Immune Modulators Go to
